Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates.

Tachmazidou I, Dedoussis G, Southam L, Farmaki AE, Ritchie GR, Xifara DK, Matchan A, Hatzikotoulas K, Rayner NW, Chen Y, Pollin TI, O'Connell JR, Yerges-Armstrong LM, Kiagiadaki C, Panoutsopoulou K, Schwartzentruber J, Moutsianas L; UK10K consortium, Tsafantakis E, Tyler-Smith C, McVean G, Xue Y, Zeggini E.

Nat Commun. 2013;4:2872. doi: 10.1038/ncomms3872.

2.

Rare variant APOC3 R19X is associated with cardio-protective profiles in a diverse population-based survey as part of the Epidemiologic Architecture for Genes Linked to Environment Study.

Crawford DC, Dumitrescu L, Goodloe R, Brown-Gentry K, Boston J, McClellan B Jr, Sutcliffe C, Wiseman R, Baker P, Pericak-Vance MA, Scott WK, Allen M, Mayo P, Schnetz-Boutaud N, Dilks HH, Haines JL, Pollin TI.

Circ Cardiovasc Genet. 2014 Dec;7(6):848-53. doi: 10.1161/CIRCGENETICS.113.000369. Epub 2014 Nov 1.

3.

The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.

Dorfmeister B, Cooper JA, Stephens JW, Ireland H, Hurel SJ, Humphries SE, Talmud PJ.

Biochim Biophys Acta. 2007 Mar;1772(3):355-63. Epub 2006 Dec 5.

4.

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.

Timpson NJ, Walter K, Min JL, Tachmazidou I, Malerba G, Shin SY, Chen L, Futema M, Southam L, Iotchkova V, Cocca M, Huang J, Memari Y, McCarthy S, Danecek P, Muddyman D, Mangino M, Menni C, Perry JR, Ring SM, Gaye A, Dedoussis G, Farmaki AE, Burton P, Talmud PJ, Gambaro G, Spector TD, Smith GD, Durbin R, Richards JB, Humphries SE, Zeggini E, Soranzo N; UK1OK Consortium Members; UK1OK Consortium Members.

Nat Commun. 2014 Sep 16;5:4871. doi: 10.1038/ncomms5871. Erratum in: Nat Commun. 2015;6:7171.

5.

Analysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study.

Adams JN, Raffield LM, Freedman BI, Langefeld CD, Ng MC, Carr JJ, Cox AJ, Bowden DW.

Cardiovasc Diabetol. 2014 Apr 12;13:77. doi: 10.1186/1475-2840-13-77.

6.

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Yin RX, Li YY, Lai CQ.

Lipids Health Dis. 2011 Aug 19;10:140. doi: 10.1186/1476-511X-10-140.

7.

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.

Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O'Connell JR, Shuldiner AR.

Science. 2008 Dec 12;322(5908):1702-5. doi: 10.1126/science.1161524.

8.

Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.

Fiegenbaum M, de Andrade FM, Hutz MH.

Clin Chim Acta. 2007 May 1;380(1-2):175-81. Epub 2007 Feb 15.

PMID:
17367769
9.

Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders.

Lahiry P, Ban MR, Pollex RL, Feldman RD, Sawyez CG, Huff MW, Young TK, Bjerregaard P, Hegele RA.

Int J Circumpolar Health. 2007 Dec;66(5):390-400.

PMID:
18274205
10.

Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.

Kozlitina J, Boerwinkle E, Cohen JC, Hobbs HH.

Hepatology. 2011 Feb;53(2):467-74. doi: 10.1002/hep.24072. Epub 2010 Dec 10.

11.

Associations between incident ischemic stroke events and stroke and cardiovascular disease-related genome-wide association studies single nucleotide polymorphisms in the Population Architecture Using Genomics and Epidemiology study.

Carty CL, Buzková P, Fornage M, Franceschini N, Cole S, Heiss G, Hindorff LA, Howard BV, Mann S, Martin LW, Zhang Y, Matise TC, Prentice R, Reiner AP, Kooperberg C.

Circ Cardiovasc Genet. 2012 Apr 1;5(2):210-6. doi: 10.1161/CIRCGENETICS.111.962191. Epub 2012 Mar 8. Erratum in: Circ Cardiovasc Genet. 2013 Aug;6(4):e10.

12.

Resequencing of LPL in African Blacks and associations with lipoprotein-lipid levels.

Pirim D, Wang X, Radwan ZH, Niemsiri V, Bunker CH, Barmada MM, Kamboh MI, Demirci FY.

Eur J Hum Genet. 2015 Sep;23(9):1244-53. doi: 10.1038/ejhg.2014.268. Epub 2015 Jan 28.

13.

Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, Auer PL, Crosslin DR, Stitziel NO, Lange LA, Lu Y, Tang ZZ, Zhang H, Hindy G, Masca N, Stirrups K, Kanoni S, Do R, Jun G, Hu Y, Kang HM, Xue C, Goel A, Farrall M, Duga S, Merlini PA, Asselta R, Girelli D, Olivieri O, Martinelli N, Yin W, Reilly D, Speliotes E, Fox CS, Hveem K, Holmen OL, Nikpay M, Farlow DN, Assimes TL, Franceschini N, Robinson J, North KE, Martin LW, DePristo M, Gupta N, Escher SA, Jansson JH, Van Zuydam N, Palmer CN, Wareham N, Koch W, Meitinger T, Peters A, Lieb W, Erbel R, Konig IR, Kruppa J, Degenhardt F, Gottesman O, Bottinger EP, O'Donnell CJ, Psaty BM, Ballantyne CM, Abecasis G, Ordovas JM, Melander O, Watkins H, Orho-Melander M, Ardissino D, Loos RJ, McPherson R, Willer CJ, Erdmann J, Hall AS, Samani NJ, Deloukas P, Schunkert H, Wilson JG, Kooperberg C, Rich SS, Tracy RP, Lin DY, Altshuler D, Gabriel S, Nickerson DA, Jarvik GP, Cupples LA, Reiner AP, Boerwinkle E, Kathiresan S.

N Engl J Med. 2014 Jul 3;371(1):22-31. doi: 10.1056/NEJMoa1307095. Epub 2014 Jun 18.

14.

Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study.

Dumitrescu L, Carty CL, Taylor K, Schumacher FR, Hindorff LA, Ambite JL, Anderson G, Best LG, Brown-Gentry K, Bůžková P, Carlson CS, Cochran B, Cole SA, Devereux RB, Duggan D, Eaton CB, Fornage M, Franceschini N, Haessler J, Howard BV, Johnson KC, Laston S, Kolonel LN, Lee ET, MacCluer JW, Manolio TA, Pendergrass SA, Quibrera M, Shohet RV, Wilkens LR, Haiman CA, Le Marchand L, Buyske S, Kooperberg C, North KE, Crawford DC.

PLoS Genet. 2011 Jun;7(6):e1002138. doi: 10.1371/journal.pgen.1002138. Epub 2011 Jun 30.

15.

Genetic contribution of SCARB1 variants to lipid traits in African Blacks: a candidate gene association study.

Niemsiri V, Wang X, Pirim D, Radwan ZH, Bunker CH, Barmada MM, Kamboh MI, Demirci FY.

BMC Med Genet. 2015 Nov 12;16:106. doi: 10.1186/s12881-015-0250-6.

16.
17.

D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.

Valleix S, Verona G, Jourde-Chiche N, Nédelec B, Mangione PP, Bridoux F, Mangé A, Dogan A, Goujon JM, Lhomme M, Dauteuille C, Chabert M, Porcari R, Waudby CA, Relini A, Talmud PJ, Kovrov O, Olivecrona G, Stoppini M, Christodoulou J, Hawkins PN, Grateau G, Delpech M, Kontush A, Gillmore JD, Kalopissis AD, Bellotti V.

Nat Commun. 2016 Jan 21;7:10353. doi: 10.1038/ncomms10353.

18.

A nonsynonymous SNP in BANK1 is associated with serum LDL cholesterol levels in three Korean populations.

Hong KW, Lyu J, Lee SH, Choi BY, Kim SS, Kim Y.

J Hum Genet. 2015 Mar;60(3):113-8. doi: 10.1038/jhg.2014.108. Epub 2015 Jan 22.

PMID:
25608828
19.

Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study.

Humphries SE, Berglund L, Isasi CR, Otvos JD, Kaluski D, Deckelbaum RJ, Shea S, Talmud PJ.

Nutr Metab Cardiovasc Dis. 2002 Aug;12(4):163-72.

PMID:
12514935
20.

Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.

Chasman DI, Paré G, Zee RY, Parker AN, Cook NR, Buring JE, Kwiatkowski DJ, Rose LM, Smith JD, Williams PT, Rieder MJ, Rotter JI, Nickerson DA, Krauss RM, Miletich JP, Ridker PM.

Circ Cardiovasc Genet. 2008 Oct;1(1):21-30. doi: 10.1161/CIRCGENETICS.108.773168.

Supplemental Content

Support Center